ResMed (RMD)
(Delayed Data from NYSE)
$204.83 USD
+5.05 (2.53%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $204.99 +0.16 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Revenue - Line of Business Segments | YR Estimate | 06/30/2023 | 06/30/2022 | 06/30/2021 | 06/30/2020 | 06/30/2019 |
---|---|---|---|---|---|---|
Global revenue: Devices [$M] |
-- | 2,271 | 1,867 | 1,610 | 1,508 | 1,362 |
Global revenue: Masks [$M] |
-- | 1,454 | 1,310 | 1,213 | 1,095 | 969 |
Global revenue: Total Sleep and R... |
-- | 3,725 | 3,177 | 2,823 | 2,602 | 2,331 |
Global revenue: Software as a Ser... |
-- | 498 | 401 | 374 | 355 | 276 |
Revenue - Geographic Segments | YR Estimate | 06/30/2023 | 06/30/2022 | 06/30/2021 | 06/30/2020 | 06/30/2019 |
U.S., Canada, and Latin America: ... |
-- | 1,444 | 1,070 | 864 | 793 | 743 |
U.S., Canada, and Latin America: ... |
-- | 1,039 | 911 | 841 | 780 | 677 |
U.S., Canada, and Latin America: ... |
-- | 2,483 | 1,982 | 1,705 | 1,927 | 1,696 |
Combined Europe, Asia, and other ... |
-- | 826 | 796 | 746 | 715 | 619 |
Combined Europe, Asia, and other ... |
-- | 415 | 399 | 372 | 315 | 292 |
Combined Europe, Asia, and other ... |
-- | 1,242 | 1,195 | 1,118 | 1,030 | 910 |